| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.062 | 0.3 |